The Role of Lazertinib in Patients With EGFR-Variant Non-Small Cell Lung Cancer

被引：0
|
作者：
Cheng, Haiying [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Montefiore Einstein Comprehens Canc Ctr, Dept Med Oncol, 1695 Eastchester Rd,2nd Floor, New York, NY 10461 USA
来源：
JAMA ONCOLOGY | 2024年 / 10卷 / 10期
关键词：
D O I：
10.1001/jamaoncol.2024.2607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1352 / 1353
页数：2
相关论文
共 50 条
  • [21] EGFR mutation profile in Australian patients with non-small cell lung cancer
    Mead, Scott
    Lucas, Mark
    Pang, Jia-Min
    Fellowes, Andrew
    Harraway, James
    Svobodova, Suzanne
    Amanuel, Benhur
    Fox, Stephen
    PATHOLOGY, 2021, 53 (07) : 933 - 936
  • [22] Leptomeningeal metastases in non-small cell lung cancer patients with EGFR mutations
    Li, Y-S.
    Jiang, B-Y.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancer
    Huh, Ki Young
    Lim, Yeji
    Yoon, Deok Yong
    Hwang, Jun Gi
    Sim, Sujin
    Kang, Jiah
    Wang, Jangyoung
    Kim, Mikyung
    Jang, Seong Bok
    Shreeve, S. Martin
    Mehta, Jaydeep
    Haddish-Berhane, Nahor
    Oh, Jaeseong
    Lee, Seunghwan
    Yu, Kyung-Sang
    LUNG CANCER, 2023, 175 : 112 - 120
  • [24] EGFR Mutation Testing in Non-Small Cell Lung Cancer
    Sriram, Krishna B.
    Francis, Santiyagu M. Savarimuthu
    Tan, Maxine E.
    Bowman, Rayleen V.
    Yang, Ian A.
    Fong, Kwun M.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (04) : 310 - 321
  • [25] Is EGFR expression important in non-small cell lung cancer?
    Lee, SM
    THORAX, 2006, 61 (02) : 98 - 99
  • [26] EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
    Gerber, David E.
    DRUG DEVELOPMENT RESEARCH, 2008, 69 (06) : 359 - 372
  • [27] Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
    Crintea, Andreea
    Constantin, Anne-Marie
    Motofelea, Alexandru C.
    Crivii, Carmen-Bianca
    Velescu, Maria A.
    Coseriu, Razvan L.
    Ilyes, Tamas
    Craciun, Alexandra M.
    Silaghi, Ciprian N.
    JOURNAL OF FUNCTIONAL BIOMATERIALS, 2023, 14 (09)
  • [28] Miliary EGFR mutated non-small cell lung cancer
    Nguyen, Mike M.
    Moore, Melissa M.
    MEDICAL JOURNAL OF AUSTRALIA, 2021, 214 (03) : 118 - 118
  • [29] Prevalence of the synonymous EGFR Q787Q variant in Mexican patients with non-small cell lung cancer
    Ramos-Ramirez, M.
    Hernandez-Pedro, N. Y.
    Arroyo-Hernandez, M.
    Aviles-Salas, A.
    Miranda, L. A. Cabrera
    Martinez-Perez, K.
    Monraz-Perez, S.
    Rodriguez, O. G. Arrieta
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1068 - S1068
  • [30] The role of EGFR tyrosine kinase inhibitors in the treatment of non-small cell lung cancer
    Kowalczyk, Anna
    Szutowicz-Zielinska, Ewa
    Dziadziuszko, Rafal
    Jassem, Jacek
    ONCOLOGY IN CLINICAL PRACTICE, 2005, 1 (04): : 217 - 224
12345